JAX-Viking
Member
The Indian generic market is the most significant near-term development for access and cost. Patent expiry timelines vary by country, but once generics hit the US market the pricing picture changes substantially. Compounding pharmacies have already shifted the landscape; the generic pharmaceutical wave is the next stage.
